Drug Type Small molecule drug |
Synonyms EIP 200, EIP-200 |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization EIP Pharma, Inc.Startup |
Active Organization EIP Pharma, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Central Nervous System Diseases | Preclinical | US | EIP Pharma, Inc.Startup | 10 Apr 2023 |